What are some success stories of CRISPR in cancer treatment?

One success story is of a breast cancer patient. She had been through various treatments with limited success. Then she tried DCA, and over time, her cancer markers in the blood decreased, indicating that the cancer was being held in check. It seems that DCA's effect on the cancer cell's metabolism was key here.

A breast cancer patient had a great success with capecitabine. Her cancer had spread to nearby lymph nodes. After capecitabine treatment, the spread was contained, and the primary tumor also shrank. This led to a reduction in the symptoms she was experiencing like pain and swelling in the breast area.

One patient had a large liver tumor. After chemoembolization, the tumor shrank enough that other treatment options became available. It was a great success as it bought more time for the patient.

There are cases where patients with colorectal cancer that had spread to the liver had successful y90 treatment. The y90 particles were able to precisely target the cancer cells in the liver. As a result, the cancer growth was halted and in some cases, reversed. These patients had better survival rates and a better quality of life compared to those who did not receive the treatment. It's because y90 treatment is less invasive compared to some other options and can be very effective in the right cases.

There are success stories in patients with refractory colorectal cancer. Panitumumab has been able to control the disease progression in some of these difficult - to - treat cases. It works by blocking the EGFR pathway, which is often overactive in cancer cells. By doing so, it stops the cancer from growing and spreading, as seen in the cases where patients' symptoms improved and they had longer survival times.

One success story is in the treatment of sickle cell disease. Scientists used CRISPR to edit the genes in patients' blood - forming stem cells to correct the genetic mutation causing the disease. This has the potential to provide a long - term cure for patients who previously had few treatment options.

One remarkable success story involves a patient with esophageal cancer. Cyramza was used when the cancer was in an advanced stage. Despite the odds, it helped to stabilize the patient's condition. The patient's pain was better managed, and they were able to eat more comfortably. This was mainly because the drug's action on the cancer cells reduced the pressure on the esophagus caused by the tumor.

A patient with ovarian cancer had a positive response to gemcitabine. The drug helped in shrinking the tumors and reducing the spread of cancer cells. This led to an increase in her survival time and a better quality of life during the treatment.

A common success story is when a patient's cancer symptoms improve. For example, if a patient had been experiencing abdominal pain and bleeding due to colorectal cancer, after Folfox treatment, these symptoms may disappear. This indicates that the treatment is working to target the cancer cells.

One notable success is in lung cancer treatment. Tecentriq has helped some lung cancer patients live longer. It does this by enhancing the body's immune response against the cancer cells in the lungs. Another is in bladder cancer. In some patients, it has reduced the size of tumors significantly.